Target intelligence / Profile preview

RPS3A pseudogene 21 (RPS3AP21)

Target: RPS3AP21
Molecular classification: Other (Pseudogene)

Overview

RPS3A pseudogene 21 is a processed pseudogene in the human genome, related to the ribosomal protein S3A gene, which encodes a structural component of the 40S ribosomal subunit. Pseudogenes like RPS3AP21 do not code for functional proteins and generally lack biological activity. They arise from duplication or retrotransposition events involving protein-coding parental genes. RPS3AP21 is considered non-functional and not implicated as a therapeutic target, nor is it known to have disease roles, interact with drugs, function as a biomarker, or present notable safety concerns.

Other names: RPS3A_7_600ribosomal protein S3a pseudogene 21RPS3AP21

Beyond the preview

Go deeper on RPS3A pseudogene 21 (RPS3AP21).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RPS3A pseudogene 21 (RPS3AP21).

Explore the full profile